Global Influenza Vaccine Market Insights, Forecast to 2028

Global Influenza Vaccine Market Insights, Forecast to 2028

Table of Contents
1 STUDY COVERAGE 1
1.1 Influenza Vaccine Product Introduction 1
1.2 Market by Type 1
1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1
1.2.2 Trivalent Influenza Vaccine 3
1.2.3 Quadrivalent Influenza Vaccine 4
1.3 Market by Application 5
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 5
1.3.2 For Children (6 months to 3 years) 7
1.3.3 For Adults and Children over 3 years 8
1.4 Study Objectives 8
1.5 Years Considered 9
2 EXECUTIVE SUMMARY 10
2.1 Global Influenza Vaccine Sales Estimates and Forecasts 2017-2028 10
2.2 Global Influenza Vaccine Revenue Estimates and Forecasts 2017-2028 11
2.3 Global Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028 12
2.4 Global Influenza Vaccine Sales by Region 14
2.4.1 Global Influenza Vaccine Sales by Region (2017-2022) 14
2.4.2 Global Sales Influenza Vaccine by Region (2023-2028) 15
2.5 Global Influenza Vaccine Revenue by Region 16
2.5.1 Global Influenza Vaccine Revenue by Region (2017-2022) 16
2.5.2 Global Influenza Vaccine Revenue by Region (2023-2028) 17
2.6 North America 18
2.7 Europe 19
2.8 Asia-Pacific 20
2.9 South America 21
2.10 Middle East & Africa 22
3 COMPETITION BY MANUFACTURERS 23
3.1 Global Influenza Vaccine Sales by Manufacturers 23
3.1.1 Global Influenza Vaccine Sales by Manufacturers (2020-2022) 23
3.1.2 Global Influenza Vaccine Sales Market Share by Manufacturers (2020-2022) 24
3.1.3 Global Top Largest Manufacturers of Influenza Vaccine in 2021 24
3.2 Global Influenza Vaccine Revenue by Manufacturers 25
3.2.1 Global Influenza Vaccine Revenue by Manufacturers (2020-2022) 25
3.2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2020-2022) 26
3.2.3 Global Top Companies by Influenza Vaccine Revenue in 2021 27
3.3 Global Influenza Vaccine Sales Price by Manufacturers (2020-2022) 27
3.4 Analysis of Competitive Landscape 28
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 28
3.4.2 Global Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) 29
3.4.3 Global Influenza Vaccine Manufacturers Geographical Distribution 30
3.5 Mergers & Acquisitions, Expansion Plans 31
4 MARKET SIZE BY TYPE 35
4.1 Global Influenza Vaccine Sales by Type 35
4.1.1 Global Influenza Vaccine Historical Sales by Type (2017-2022) 35
4.1.2 Global Influenza Vaccine Forecasted Sales by Type (2023-2028) 35
4.1.3 Global Influenza Vaccine Sales Market Share by Type (2017-2028) 35
4.2 Global Influenza Vaccine Revenue by Type 36
4.2.1 Global Influenza Vaccine Historical Revenue by Type (2017-2022) 36
4.2.2 Global Influenza Vaccine Forecasted Revenue by Type (2023-2028) 37
4.2.3 Global Influenza Vaccine Revenue Market Share by Type (2017-2028) 37
4.3 Global Influenza Vaccine Price by Type 38
4.3.1 Global Influenza Vaccine Price by Type (2017-2022) 38
4.3.2 Global Influenza Vaccine Price Forecast by Type (2023-2028) 38
5 MARKET SIZE BY APPLICATION 39
5.1 Global Influenza Vaccine Sales by Application 39
5.1.1 Global Influenza Vaccine Historical Sales by Application (2017-2022) 39
5.1.2 Global Influenza Vaccine Forecasted Sales by Application (2023-2028) 39
5.1.3 Global Influenza Vaccine Sales Market Share by Application (2017-2028) 39
5.2 Global Influenza Vaccine Revenue by Application 40
5.2.1 Global Influenza Vaccine Historical Revenue by Application (2017-2022) 40
5.2.2 Global Influenza Vaccine Forecasted Revenue by Application (2023-2028) 41
5.2.3 Global Influenza Vaccine Revenue Market Share by Application (2017-2028) 41
5.3 Global Influenza Vaccine Price by Application 42
5.3.1 Global Influenza Vaccine Price by Application (2017-2022) 42
5.3.2 Global Influenza Vaccine Price Forecast by Application (2023-2028) 42
6 NORTH AMERICA 43
6.1 North America Influenza Vaccine Market Size by Type 43
6.1.1 North America Influenza Vaccine Sales by Type (2017-2028) 43
6.1.2 North America Influenza Vaccine Revenue by Type (2017-2028) 44
6.2 North America Influenza Vaccine Market Size by Application 45
6.3 North America Influenza Vaccine Sales by Country 46
6.3.1 North America Influenza Vaccine Sales by Country (2017-2028) 46
6.3.2 North America Influenza Vaccine Revenue by Country (2017-2028) 47
6.3.3 U.S. 48
6.3.4 Canada 48
6.3.5 Mexico 49
7 EUROPE 50
7.1 Europe Influenza Vaccine Market Size by Type 50
7.1.1 Europe Influenza Vaccine Sales by Type (2017-2028) 50
7.1.2 Europe Influenza Vaccine Revenue by Type (2017-2028) 51
7.2 Europe Influenza Vaccine Market Size by Application 52
7.3 Europe Influenza Vaccine Market Size by Country 53
7.3.1 Europe Influenza Vaccine Sales by Country (2017-2028) 53
7.3.2 Europe Influenza Vaccine Revenue by Country (2017-2028) 54
7.3.3 Germany 55
7.3.4 France 56
7.3.5 U.K. 56
7.3.6 Italy 57
7.3.7 Russia 57
8 ASIA PACIFIC 58
8.1 Asia Pacific Influenza Vaccine Market Size by Type 58
8.1.1 Asia Pacific Influenza Vaccine Sales by Type (2017-2028) 58
8.1.2 Asia Pacific Influenza Vaccine Revenue by Type (2017-2028) 59
8.2 Asia Pacific Influenza Vaccine Market Size by Application 60
8.3 Asia Pacific Influenza Vaccine Market Size by Region 61
8.3.1 Asia Pacific Influenza Vaccine Sales by Region (2017-2028) 61
8.3.2 Asia Pacific Influenza Vaccine Revenue by Region (2017-2028) 62
8.3.3 China 64
8.3.4 Japan 64
8.3.5 South Korea 65
8.3.6 India 65
8.3.7 Australia 66
8.3.8 Southeast Asia 66
9 SOUTH AMERICA 67
9.1 South America Influenza Vaccine Market Size by Type 67
9.1.1 South America Influenza Vaccine Sales by Type (2017-2028) 67
9.1.2 South America Influenza Vaccine Revenue by Type (2017-2028) 68
9.2 South America Influenza Vaccine Market Size by Application 69
9.3 South America Influenza Vaccine Market Size by Country 70
9.3.1 South America Influenza Vaccine Sales by Country (2017-2028) 70
9.3.2 South America Influenza Vaccine Revenue by Country (2017-2028) 71
9.3.3 Brazil 72
10 MIDDLE EAST AND AFRICA 73
10.1 Middle East and Africa Influenza Vaccine Market Size by Type 73
10.1.1 Middle East and Africa Influenza Vaccine Sales by Type (2017-2028) 73
10.1.2 Middle East and Africa Influenza Vaccine Revenue by Type (2017-2028) 74
10.2 Middle East and Africa Influenza Vaccine Market Size by Application 75
10.3 Middle East and Africa Influenza Vaccine Market Size by Country 76
10.3.1 Middle East and Africa Influenza Vaccine Sales by Country (2017-2028) 76
10.3.2 Middle East and Africa Influenza Vaccine Revenue by Country (2017-2028) 77
10.3.3 Middle East 79
10.3.4 Africa 79
11 CORPORATE PROFILE 80
11.1 Sanofi 80
11.1.1 Sanofi Corporation Information 80
11.1.2 Sanofi Overview 80
11.1.3 Sanofi Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 81
11.1.4 Sanofi Influenza Vaccine Product Introduction 81
11.1.5 Sanofi Recent Developments 83
11.2 CSL 84
11.2.1 CSL Corporation Information 84
11.2.2 CSL Overview 84
11.2.3 CSL Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 85
11.2.4 CSL Influenza Vaccine Product Introduction 86
11.2.5 CSL Recent Developments 86
11.3 GSK 88
11.3.1 GSK Corporation Information 88
11.3.2 GSK Overview 89
11.3.3 GSK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 89
11.3.4 GSK Influenza Vaccine Product Introduction 90
11.4 Viatris 91
11.4.1 Viatris Corporation Information 91
11.4.2 Viatris Overview 92
11.4.3 Viatris Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 92
11.4.4 Viatris Influenza Vaccine Product Introduction 93
11.4.5 Viatris Recent Developments 93
11.5 AstraZeneca 94
11.5.1 AstraZeneca Corporation Information 94
11.5.2 AstraZeneca Overview 95
11.5.3 AstraZeneca Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 95
11.5.4 AstraZeneca Influenza Vaccine Product Introduction 96
11.5.5 AstraZeneca Recent Developments 97
11.6 Hualan Bio 97
11.6.1 Hualan Bio Corporation Information 97
11.6.2 Hualan Bio Overview 98
11.6.3 Hualan Bio Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 99
11.6.4 Hualan Bio Influenza Vaccine Product Introduction 99
11.7 Changchun Institute of Biological 100
11.7.1 Changchun Institute of Biological Corporation Information 100
11.7.2 Changchun Institute of Biological Overview 101
11.7.3 Changchun Institute of Biological Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 102
11.7.4 Changchun Institute of Biological Influenza Vaccine Product Introduction 102
11.7.5 Changchun Institute of Biological Recent Developments 103
11.8 Sinovac 103
11.8.1 Sinovac Corporation Information 103
11.8.2 Sinovac Overview 104
11.8.3 Sinovac Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 104
11.8.4 Sinovac Influenza Vaccine Product Introduction 104
11.8.5 Sinovac Recent Developments 106
11.9 BCHT 106
11.9.1 BCHT Corporation Information 106
11.9.2 BCHT Overview 107
11.9.3 BCHT Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 108
11.9.4 BCHT Influenza Vaccine Product Introduction 108
11.9.5 BCHT Recent Developments 109
11.10 Jiangsu GDK 110
11.10.1 Jiangsu GDK Corporation Information 110
11.10.2 Jiangsu GDK Overview 111
11.10.3 Jiangsu GDK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 112
11.10.4 Jiangsu GDK Influenza Vaccine Product Introduction 112
11.11 KM Biologics 113
11.11.1 KM Biologics Corporation Information 113
11.11.2 KM Biologics Overview 113
11.11.3 KM Biologics Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 115
11.11.4 KM Biologics Influenza Vaccine Product Introduction 115
11.11.5 KM Biologics Recent Developments 116
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 118
12.1 Influenza Vaccine Industry Chain Analysis 118
12.2 Influenza Vaccine Key Raw Materials 119
12.2.1 Key Raw Materials 119
12.2.2 Raw Materials Key Suppliers 119
12.3 Influenza Vaccine Production Mode & Process 121
12.4 Influenza Vaccine Sales and Marketing 122
12.4.1 Influenza Vaccine Sales Channels 122
12.4.2 Influenza Vaccine Distributors 123
12.5 Influenza Vaccine Customers 125
13 INFLUENZA VACCINE MARKET DYNAMICS 129
13.1.1 Influenza Vaccine Industry Trends 129
13.1.2 Influenza Vaccine Market Drivers 130
13.1.3 Influenza Vaccine Market Challenges 131
13.1.4 Influenza Vaccine Market Restraints 131
14 KEY FINDINGS IN THE GLOBAL INFLUENZA VACCINE STUDY 132
15 APPENDIX 134
15.1 Research Methodology 134
15.1.1 Methodology/Research Approach 134
15.1.2 Data Source 137
15.2 Author Details 140
15.3 Disclaimer 140
List of Tables
Table 1. Global Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) 2
Table 2. Major Manufacturers of Quadrivalent Influenza Vaccine 5
Table 3. Global Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) 5
Table 4. Global Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) 12
Table 5. Global Influenza Vaccine Sales by Region (2017-2022) & (M Doses) 14
Table 6. Global Influenza Vaccine Sales Market Share by Region (2017-2022) 14
Table 7. Global Influenza Vaccine Sales by Region (2023-2028) & (M Doses) 15
Table 8. Global Influenza Vaccine Sales Market Share by Region (2023-2028) 15
Table 9. Global Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million) 16
Table 10. Global Influenza Vaccine Revenue Market Share by Region (2017-2022) 17
Table 11. Global Influenza Vaccine Revenue by Region (2023-2028) & (US$ Million) 17
Table 12. Global Influenza Vaccine Revenue Market Share by Region (2023-2028) 17
Table 13. Global Influenza Vaccine Sales by Manufacturers (2020-2022) & (M Doses) 23
Table 14. Global Influenza Vaccine Sales Share by Manufacturers (2020-2022) 24
Table 15. Global Influenza Vaccine Revenue by Manufacturers (2020-2022) & (US$ Million) 26
Table 16. Global Influenza Vaccine Revenue Market Share by Manufacturers (2020-2022) 26
Table 17. Influenza Vaccine Price by Manufacturers (2020-2022) & (USD/Doses) 28
Table 18. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) 29
Table 19. Global Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2021) 29
Table 20. Influenza Vaccine Manufacturing Base Distribution and Headquarters 30
Table 21. Manufacturers Influenza Vaccine Product Offered 30
Table 22. Founded Date of Influenza Vaccine Manufacturers 31
Table 23. Mergers & Acquisitions, Expansion Plans 31
Table 24. Global Influenza Vaccine Sales by Type (2017-2022) & (M Doses) 35
Table 25. Global Influenza Vaccine Sales by Type (2023-2028) & (M Doses) 35
Table 26. Global Influenza Vaccine Sales Share by Type (2017-2022) 35
Table 27. Global Influenza Vaccine Sales Share by Type (2023-2028) 36
Table 28. Global Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million) 36
Table 29. Global Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million) 37
Table 30. Global Influenza Vaccine Revenue Share by Type (2017-2022) 37
Table 31. Global Influenza Vaccine Revenue Share by Type (2023-2028) 37
Table 32. Influenza Vaccine Price by Type (2017-2022) & (USD/Doses) 38
Table 33. Global Influenza Vaccine Price Forecast by Type (2023-2028) & (USD/Doses) 38
Table 34. Global Influenza Vaccine Sales by Application (2017-2022) & (M Doses) 39
Table 35. Global Influenza Vaccine Sales by Application (2023-2028) & (M Doses) 39
Table 36. Global Influenza Vaccine Sales Share by Application (2017-2022) 39
Table 37. Global Influenza Vaccine Sales Share by Application (2023-2028) 40
Table 38. Global Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million) 40
Table 39. Global Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million) 41
Table 40. Global Influenza Vaccine Revenue Share by Application (2017-2022) 41
Table 41. Global Influenza Vaccine Revenue Share by Application (2023-2028) 41
Table 42. Influenza Vaccine Price by Application (2017-2022) & (USD/Doses) 42
Table 43. Global Influenza Vaccine Price Forecast by Application (2023-2028) & (USD/Doses) 42
Table 44. North America Influenza Vaccine Sales by Type (2017-2022) & (M Doses) 43
Table 45. North America Influenza Vaccine Sales by Type (2023-2028) & (M Doses) 43
Table 46. North America Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million) 44
Table 47. North America Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million) 44
Table 48. North America Influenza Vaccine Sales by Application (2017-2022) & (M Doses) 45
Table 49. North America Influenza Vaccine Sales by Application (2023-2028) & (M Doses) 45
Table 50. North America Influenza Vaccine Sales by Country (2017-2022) & (M Doses) 46
Table 51. North America Influenza Vaccine Sales by Country (2023-2028) & (M Doses) 46
Table 52. North America Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million) 47
Table 53. North America Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million) 47
Table 54. Europe Influenza Vaccine Sales by Type (2017-2022) & (M Doses) 50
Table 55. Europe Influenza Vaccine Sales by Type (2023-2028) & (M Doses) 50
Table 56. Europe Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million) 51
Table 57. Europe Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million) 51
Table 58. Europe Influenza Vaccine Sales by Application (2017-2022) & (M Doses) 52
Table 59. Europe Influenza Vaccine Sales by Application (2023-2028) & (M Doses) 52
Table 60. Europe Influenza Vaccine Sales by Country (2017-2022) & (M Doses) 53
Table 61. Europe Influenza Vaccine Sales by Country (2023-2028) & (M Doses) 53
Table 62. Europe Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million) 54
Table 63. Europe Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million) 54
Table 64. Asia Pacific Influenza Vaccine Sales by Type (2017-2022) & (M Doses) 58
Table 65. Asia Pacific Influenza Vaccine Sales by Type (2023-2028) & (M Doses) 58
Table 66. Asia Pacific Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million) 59
Table 67. Asia Pacific Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million) 59
Table 68. Asia Pacific Influenza Vaccine Sales by Application (2017-2022) & (M Doses) 60
Table 69. Asia Pacific Influenza Vaccine Sales by Application (2023-2028) & (M Doses) 60
Table 70. Asia Pacific Influenza Vaccine Sales by Region (2017-2022) & (M Doses) 61
Table 71. Asia Pacific Influenza Vaccine Sales by Region (2023-2028) & (M Doses) 61
Table 72. Asia Pacific Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million) 62
Table 73. Asia Pacific Influenza Vaccine Revenue by Region (2023-2028) & (US$ Million) 63
Table 74. South America Influenza Vaccine Sales by Type (2017-2022) & (M Doses) 67
Table 75. South America Influenza Vaccine Sales by Type (2023-2028) & (M Doses) 67
Table 76. South America Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million) 68
Table 77. South America Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million) 68
Table 78. South America Influenza Vaccine Sales by Application (2017-2022) & (M Doses) 69
Table 79. South America Influenza Vaccine Sales by Application (2023-2028) & (M Doses) 69
Table 80. South America Influenza Vaccine Sales by Country (2017-2022) & (M Doses) 70
Table 81. South America Influenza Vaccine Sales by Country (2023-2028) & (M Doses) 70
Table 82. South America Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million) 71
Table 83. South America Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million) 71
Table 84. Middle East and Africa Influenza Vaccine Sales by Type (2017-2022) & (M Doses) 73
Table 85. Middle East and Africa Influenza Vaccine Sales by Type (2023-2028) & (M Doses) 73
Table 86. Middle East and Africa Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million) 74
Table 87. Middle East and Africa Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million) 74
Table 88. Middle East and Africa Influenza Vaccine Sales by Application (2017-2022) & (M Doses) 75
Table 89. Middle East and Africa Influenza Vaccine Sales by Application (2023-2028) & (M Doses) 75
Table 90. Middle East and Africa Influenza Vaccine Sales by Country (2017-2022) & (M Doses) 76
Table 91. Middle East and Africa Influenza Vaccine Sales by Country (2023-2028) & (M Doses) 77
Table 92. Middle East and Africa Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million) 77
Table 93. Middle East and Africa Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million) 78
Table 94. Sanofi Corporation Information 80
Table 95. Sanofi Description and Major Businesses 80
Table 96. Sanofi Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2022) 81
Table 97. Sanofi Influenza Vaccine Product Introduction 81
Table 98. Sanofi Recent Developments 83
Table 99. CSL Corporation Information 84
Table 100. CSL Description and Major Businesses 84
Table 101. CSL Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2022) 85
Table 102. CSL Influenza Vaccine Product Introduction 86
Table 103. CSL Recent Developments 86
Table 104. GSK Corporation Information 88
Table 105. GSK Description and Major Businesses 89
Table 106. GSK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2022) 89
Table 107. GSK Influenza Vaccine Product Introduction 90
Table 108. Viatris Corporation Information 91
Table 109. Viatris Description and Major Businesses 92
Table 110. Viatris Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2022) 92
Table 111. Viatris Influenza Vaccine Product Introduction 93
Table 112. Viatris Recent Developments 93
Table 113. AstraZeneca Corporation Information 94
Table 114. AstraZeneca Description and Major Businesses 95
Table 115. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2022) 95
Table 116. AstraZeneca Influenza Vaccine Product Introduction 96
Table 117. AstraZeneca Recent Developments 97
Table 118. Hualan Bio Corporation Information 97
Table 119. Hualan Bio Description and Major Businesses 98
Table 120. Hualan Bio Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2022) 99
Table 121. Hualan Bio Influenza Vaccine Product Introduction 99
Table 122. Changchun Institute of Biological Corporation Information 100
Table 123. Changchun Institute of Biological Description and Major Businesses 101
Table 124. Changchun Institute of Biological Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2022) 102
Table 125. Changchun Institute of Biological Influenza Vaccine Product Introduction 102
Table 126. Changchun Institute of Biological Recent Developments 103
Table 127. Sinovac Corporation Information 103
Table 128. Sinovac Description and Major Businesses 104
Table 129. Sinovac Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2022) 104
Table 130. Sinovac Influenza Vaccine Product Introduction 104
Table 131. Sinovac Recent Developments 106
Table 132. BCHT Corporation Information 106
Table 133. BCHT Description and Major Businesses 107
Table 134. BCHT Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2022) 108
Table 135. BCHT Influenza Vaccine Product Introduction 108
Table 136. BCHT Recent Developments 109
Table 137. Jiangsu GDK Corporation Information 110
Table 138. Jiangsu GDK Description and Major Businesses 111
Table 139. Jiangsu GDK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2022) 112
Table 140. Jiangsu GDK Influenza Vaccine Product Introduction 112
Table 141. KM Biologics Corporation Information 113
Table 142. KM Biologics Description and Major Businesses 113
Table 143. KM Biologics Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2022) 115
Table 144. KM Biologics Influenza Vaccine Product Introduction 115
Table 145. KM Biologics Recent Developments 116
Table 146. Key Raw Materials Lists 119
Table 147. Raw Materials Key Suppliers Lists 119
Table 148. Influenza Vaccine Distributors List 123
Table 149. Influenza Vaccine Customers List 125
Table 150. Influenza Vaccine Market Trends 129
Table 151. Influenza Vaccine Market Drivers 130
Table 152. Influenza Vaccine Market Challenges 131
Table 153. Influenza Vaccine Market Restraints 131
Table 154. Research Programs/Design for This Report 134
Table 155. Key Data Information from Secondary Sources 137
Table 156. Key Data Information from Primary Sources 138
List of Figures
Figure 1. Influenza Vaccine Product Picture 1
Figure 2. Global Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) 2
Figure 3. Global Influenza Vaccine Market Share by Type: 2021 3
Figure 4. Global Influenza Vaccine Market Share by Type: 2028 3
Figure 5. Trivalent Influenza Vaccine Product Picture 4
Figure 6. Major Manufacturers of Trivalent Influenza Vaccine 4
Figure 7. Quadrivalent Influenza Vaccine Product Picture 5
Figure 8. Global Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) 6
Figure 9. Global Influenza Vaccine Market Share by Application: 2021 6
Figure 10. Global Influenza Vaccine Market Share by Application: 2028 7
Figure 11. For Children (6 months to 3 years) 7
Figure 12. For Adults and Children over 3 years 8
Figure 13. Influenza Vaccine Report Years Considered 9
Figure 14. Global Influenza Vaccine Sales 2017-2028 (M Doses) 10
Figure 15. Global Influenza Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028 11
Figure 16. Global Influenza Vaccine Revenue 2017-2028 (US$ Million) 12
Figure 17. Global Influenza Vaccine Revenue Market Share by Region in Percentage: 2021 13
Figure 18. Global Influenza Vaccine Revenue Market Share by Region in Percentage: 2028 13
Figure 19. Global Influenza Vaccine Sales Market Share by Region (2017-2022) 15
Figure 20. Global Influenza Vaccine Sales Market Share by Region (2023-2028) 16
Figure 21. North America Influenza Vaccine Sales YoY (2017-2028) & (M Doses) 18
Figure 22. North America Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million) 18
Figure 23. Europe Influenza Vaccine Sales YoY (2017-2028) & (M Doses) 19
Figure 24. Europe Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million) 19
Figure 25. Asia-Pacific Influenza Vaccine Sales YoY (2017-2028) & (M Doses) 20
Figure 26. Asia-Pacific Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million) 20
Figure 27. South America Influenza Vaccine Sales YoY (2017-2028) & (M Doses) 21
Figure 28. South America Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million) 21
Figure 29. Middle East & Africa Influenza Vaccine Sales YoY (2017-2028) & (M Doses) 22
Figure 30. Middle East & Africa Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million) 22
Figure 31. The Influenza Vaccine Market Share of Top Largest Manufacturers Around the World in 2021 25
Figure 32. The Top Largest Manufacturers of Influenza Vaccine in the World: Market Share by Influenza Vaccine Revenue in 2021 27
Figure 33. Global Influenza Vaccine Sales Market Share by Type (2017-2028) 36
Figure 34. Global Influenza Vaccine Revenue Market Share by Type (2017-2028) 38
Figure 35. Global Influenza Vaccine Sales Market Share by Application (2017-2028) 40
Figure 36. Global Influenza Vaccine Revenue Market Share by Application (2017-2028) 42
Figure 37. North America Influenza Vaccine Sales Market Share by Type (2017-2028) 43
Figure 38. North America Influenza Vaccine Revenue Market Share by Type (2017-2028) 44
Figure 39. North America Influenza Vaccine Sales Market Share by Application (2017-2028) 45
Figure 40. North America Influenza Vaccine Sales Share by Country (2017-2028) 46
Figure 41. North America Influenza Vaccine Revenue Share by Country (2017-2028) 47
Figure 42. U.S. Influenza Vaccine Revenue (2017-2028) & (US$ Million) 48
Figure 43. Canada Influenza Vaccine Revenue (2017-2028) & (US$ Million) 48
Figure 44. Mexico Influenza Vaccine Revenue (2017-2028) & (US$ Million) 49
Figure 45. Europe Influenza Vaccine Sales Market Share by Type (2017-2028) 50
Figure 46. Europe Influenza Vaccine Revenue Market Share by Type (2017-2028) 51
Figure 47. Europe Influenza Vaccine Sales Market Share by Application (2017-2028) 52
Figure 48. Europe Influenza Vaccine Sales Share by Country (2017-2028) 54
Figure 49. Europe Influenza Vaccine Revenue Share by Country (2017-2028) 55
Figure 50. Germany Influenza Vaccine Revenue (2017-2028) & (US$ Million) 55
Figure 51. France Influenza Vaccine Revenue (2017-2028) & (US$ Million) 56
Figure 52. U.K. Influenza Vaccine Revenue (2017-2028) & (US$ Million) 56
Figure 53. Italy Influenza Vaccine Revenue (2017-2028) & (US$ Million) 57
Figure 54. Russia Influenza Vaccine Revenue (2017-2028) & (US$ Million) 57
Figure 55. Asia Pacific Influenza Vaccine Sales Market Share by Type (2017-2028) 58
Figure 56. Asia Pacific Influenza Vaccine Revenue Market Share by Type (2017-2028) 59
Figure 57. Asia Pacific Influenza Vaccine Sales Market Share by Application (2017-2028) 60
Figure 58. Asia Pacific Influenza Vaccine Sales Share by Region (2017-2028) 62
Figure 59. Asia Pacific Influenza Vaccine Revenue Share by Region (2017-2028) 63
Figure 60. China Influenza Vaccine Revenue (2017-2028) & (US$ Million) 64
Figure 61. Japan Influenza Vaccine Revenue (2017-2028) & (US$ Million) 64
Figure 62. South Korea Influenza Vaccine Revenue (2017-2028) & (US$ Million) 65
Figure 63. India Influenza Vaccine Revenue (2017-2028) & (US$ Million) 65
Figure 64. Australia Influenza Vaccine Revenue (2017-2028) & (US$ Million) 66
Figure 65. Southeast Asia Influenza Vaccine Revenue (2017-2028) & (US$ Million) 66
Figure 66. South America Influenza Vaccine Sales Market Share by Type (2017-2028) 67
Figure 67. South America Influenza Vaccine Revenue Market Share by Type (2017-2028) 68
Figure 68. South America Influenza Vaccine Sales Market Share by Application (2017-2028) 69
Figure 69. South America Influenza Vaccine Sales Share by Country (2017-2028) 70
Figure 70. South America Influenza Vaccine Revenue Share by Country (2017-2028) 71
Figure 71. Brazil Influenza Vaccine Revenue (2017-2028) & (US$ Million) 72
Figure 72. Middle East and Africa Influenza Vaccine Sales Market Share by Type (2017-2028) 74
Figure 73. Middle East and Africa Influenza Vaccine Revenue Market Share by Type (2017-2028) 75
Figure 74. Middle East and Africa Influenza Vaccine Sales Market Share by Application (2017-2028) 76
Figure 75. Middle East and Africa Influenza Vaccine Sales Share by Country (2017-2028) 77
Figure 76. Middle East and Africa Influenza Vaccine Revenue Share by Country (2017-2028) 78
Figure 77. Middle East Influenza Vaccine Revenue (2017-2028) & (US$ Million) 79
Figure 78. Africa Influenza Vaccine Revenue (2017-2028) & (US$ Million) 79
Figure 79. Influenza Vaccine Value Chain 118
Figure 80. Influenza Vaccine Production Process 121
Figure 81. Channels of Distribution 122
Figure 82. Distributors Profiles 124
Figure 83. Bottom-up and Top-down Approaches for This Report 136
Figure 84. Data Triangulation 137
Figure 85. Key Executives Interviewed 139

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs